How does the fee structure work for extensions of time under 37 CFR 1.136(a)?
The fee structure for extensions of time under 37 CFR 1.136(a) is cumulative. The MPEP explains: The fees for extensions of time under 37 CFR 1.136(a) are set forth in 37 CFR 1.17(a) and are subject to a 50% reduction for persons or concerns qualifying as small entities. The fees itemized at 37 CFR 1.17(a)…
Read MoreWhen can a patent examiner question test results in a patent application?
A patent examiner can question test results in a patent application when there is a reasonable basis for doing so. The Manual of Patent Examining Procedure (MPEP) 707.07(l) states: The results of the tests and examples should not normally be questioned by the examiner unless there is reasonable basis for questioning the results. If an…
Read MoreHow should patent examiners approach claim rejections?
According to MPEP 707.07(g), patent examiners should approach claim rejections comprehensively. The MPEP states, “The examiner ordinarily should reject each claim on all valid grounds available, avoiding, however, undue multiplication of references.” This means that examiners should: Address all valid grounds for rejection in a single office action Apply rejections for issues such as lack…
Read MoreWhat are the time limits for extensions under 37 CFR 1.136(a)?
According to 37 CFR 1.136(a), an applicant may extend the time period for reply up to five months after the time period set for reply, unless: Prohibited by statute Prohibited by one of the items listed in the rule The applicant has been notified otherwise in an Office action The MPEP states: 37 CFR 1.136(a)…
Read MoreNo more FAQs can be generated
All possible FAQs have been exhausted and no further meaningful questions can be generated from the given MPEP section without significant repetition or overlap with existing questions. To learn more: MPEP affidavits 37 CFR 1.131(a) 37 CFR 1.132 To learn more: Patent Examination Information Requirement Duty of Disclosure
Read MoreNo more FAQs
All relevant information from MPEP 714.07 – Amendments Not in Permanent Ink has been covered in previously generated FAQs. No additional meaningful questions can be created based on the given content. To learn more: Patent amendments permanent ink USPTO requirements To learn more: Patentability Report P.R. MPEP
Read MoreWhat does ‘No Inter Partes Questions Discussed Ex Parte’ mean in patent examination?
In patent examination, ‘No Inter Partes Questions Discussed Ex Parte’ means that an examiner is not allowed to discuss issues involving multiple parties (inter partes) with only one party present (ex parte). The Manual of Patent Examining Procedure (MPEP) Section 713.06 states: The examiner may not discuss inter partes questions ex parte with any of…
Read MoreNo Additional FAQs
All relevant information from MPEP 803.01 – Review by Examiner with at Least Partial Signatory Authority has been covered in previously generated FAQs. No additional meaningful questions can be formulated without redundancy or speculation beyond the provided content. To learn more: MPEP Patent Examination Restriction Requirements
Read MoreHow does MPEP 711.05 relate to other sections of the MPEP regarding abandonment?
MPEP 711.05 specifically addresses letters of abandonment received after an application is allowed. It relates to other sections of the MPEP, particularly those dealing with abandonment procedures. For instance, the section mentions: See also MPEP § 711.01. This reference to MPEP 711.01 suggests that there are related procedures and considerations for express abandonment in general…
Read MoreHow does the MPEP define ‘commercial success’ in patent examination?
The Manual of Patent Examining Procedure (MPEP) does not provide a specific definition for ‘commercial success.’ However, it outlines the requirements for using commercial success as evidence of non-obviousness. According to MPEP 716.03(a): An applicant who is asserting commercial success to support its contention of nonobviousness bears the burden of proof of establishing a nexus…
Read More